CORD-19:dc97e1de3b69da13f534f15afdcedbf48064c69d / 450011-450183 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T78283","span":{"begin":0,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Treatment of DKA or nonketotic hyperosmolar syndrome is aimed at reducing ketoacid production, stimulating carbohydrate use, and impeding peripheral release of fatty acids."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T45","span":{"begin":0,"end":172},"obj":"Sentence"}],"text":"Treatment of DKA or nonketotic hyperosmolar syndrome is aimed at reducing ketoacid production, stimulating carbohydrate use, and impeding peripheral release of fatty acids."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T2071","span":{"begin":13,"end":16},"obj":"Phenotype"}],"attributes":[{"id":"A2071","pred":"hp_id","subj":"T2071","obj":"http://purl.obolibrary.org/obo/HP_0001953"}],"text":"Treatment of DKA or nonketotic hyperosmolar syndrome is aimed at reducing ketoacid production, stimulating carbohydrate use, and impeding peripheral release of fatty acids."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2089","span":{"begin":13,"end":16},"obj":"Disease"},{"id":"T53819","span":{"begin":13,"end":16},"obj":"Disease"}],"attributes":[{"id":"A2089","pred":"mondo_id","subj":"T2089","obj":"http://purl.obolibrary.org/obo/MONDO_0012819"},{"id":"A58562","pred":"mondo_id","subj":"T53819","obj":"http://purl.obolibrary.org/obo/MONDO_0012819"}],"text":"Treatment of DKA or nonketotic hyperosmolar syndrome is aimed at reducing ketoacid production, stimulating carbohydrate use, and impeding peripheral release of fatty acids."}